pyrimidin-2-one beta-ribofuranoside has been researched along with Adenoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clayton, RN; Duong, CV; Farrell, WE; Yacqub-Usman, K | 1 |
| Clayton, RN; Emes, RD; Farrell, WE; Kitchen, MO; Richardson, A; Yacqub-Usman, K | 1 |
2 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Adenoma
| Article | Year |
|---|---|
Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes.
Topics: Adenoma; Animals; Bone Morphogenetic Protein 4; Cell Culture Techniques; Cytidine; Drug Synergism; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mice; Pituitary Neoplasms; Prodrugs; Receptors, Dopamine D2; Time Factors; Tretinoin; Tumor Cells, Cultured | 2013 |
Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Topics: Adenoma; Animals; Antineoplastic Agents; Cell Line; Chromatin Assembly and Disassembly; CpG Islands; Cytidine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; HMGA Proteins; HMGA2 Protein; Humans; Hydroxamic Acids; MicroRNAs; Pituitary Gland; Pituitary Neoplasms; Rats; Rats, Sprague-Dawley; Up-Regulation | 2015 |